The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity.
COVID-19
SARS-CoV-2
hospital bed capacity
intensive care
mathematical model
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
04 05 2021
04 05 2021
Historique:
received:
18
06
2020
accepted:
02
07
2020
pubmed:
7
7
2020
medline:
8
5
2021
entrez:
7
7
2020
Statut:
ppublish
Résumé
Countries such as South Africa have limited intensive care unit (ICU) capacity to handle the expected number of patients with COVID-19 requiring ICU care. Remdesivir can prevent deaths in countries such as South Africa by decreasing the number of days people spend in ICU, therefore freeing up ICU bed capacity.
Identifiants
pubmed: 32628744
pii: 5868030
doi: 10.1093/cid/ciaa937
pmc: PMC7454458
doi:
Substances chimiques
remdesivir
3QKI37EEHE
Adenosine Monophosphate
415SHH325A
Alanine
OF5P57N2ZX
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1642-1644Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.